Coraza, Rio Kyler U.
HRN: 25-13-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2024
OXACILLIN 500MG (VIAL)
12/23/2024
12/30/2024
IV
200 Mg
Q 6 Hours
Bacterial Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes